Submit Deal

Announced

30 Jul 2025

Aurobindo Pharma to acquire Lannett Company for $250m.

Synopsis

Aurobindo Pharma, a leading integrated global pharmaceutical company, agreed to acquire Lannett Company, a US-based pharmaceutical manufacturer and supplier specializing in complex generics, for $250m.

Principals

target

Lannett Company

bidder

Aurobindo Pharma

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

raymond james

HQ - St. Petersburg, Florida, United States

financial advisors

target

941

Deals

£ 146.71 B

Total Value

dechert

HQ - Philadelphia

legal advisors

target

535

Deals

£ 307.42 B

Total Value

honigman llp

legal advisors

target

Deal

£ 188 M

Total Value

sagene advisor

financial advisors

bidder

Deal

£ 188 M

Total Value

usi advisors

technical advisors

bidder

Deals

£ 188 M

Total Value

knav

financial advisors

bidder

Deals

£ 188 M

Total Value

sullivan & cromwell

HQ - New York

legal advisors

bidder

1461

Deals

£ 3,576.44 B

Total Value

ice miller

HQ - Indianapolis, Indiana

legal advisors

bidder

Deals

£ 6.31 B

Total Value

khaitan & co

HQ - Kolkata, India

legal advisors

bidder

823

Deals

£ 174.65 B

Total Value

ey india

financial advisors

bidder

Deal

£ 188 M

Total Value

ies consulting

environmental advisors

bidder

Deal

£ 188 M

Total Value